Literature DB >> 30575956

Physical exercise for people with cirrhosis.

Luise Aamann1, Gitte Dam, Anders R Rinnov, Hendrik Vilstrup, Lise Lotte Gluud.   

Abstract

BACKGROUND: Loss of muscle mass and muscle weakness are common complications to cirrhosis and are associated with increased morbidity and mortality. Therefore, physical exercise may benefit people with cirrhosis.
OBJECTIVES: To assess the beneficial and harmful effects of physical exercise versus sham exercise or no exercise for people with cirrhosis. SEARCH
METHODS: We searched The Cochrane Hepato-Biliary Group Controlled Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE Ovid, Embase Ovid, and three other databases, including manual searches through reference lists, abstracts, and presentations at conferences and meetings, Google Scholar, and online trial registers in February 2018. SELECTION CRITERIA: We included randomised clinical trials regardless of publication status or language. Inclusion criteria were cirrhosis irrespective of the aetiology or stage. Interventions were physical exercise compared with sham exercise or no intervention. DATA COLLECTION AND ANALYSIS: Three review authors independently extracted data. We undertook meta-analyses and presented results using risk ratios (RR) for dichotomous outcomes and mean differences (MD) for continuous outcomes, both with 95% confidence intervals (CI) and I2 values as markers of imprecision and heterogeneity. We assessed bias control using the Cochrane Hepato-Biliary Group domains and determined the credibility of the evidence using GRADE. MAIN
RESULTS: We included six randomised clinical trials with 173 participants. All participants had Child-Pugh stage A or B cirrhosis. The intervention groups participated in eight to 14 weeks of physical exercise (aerobic: three trials; resistance: one trial; or aerobic plus resistance training: two trials). Control groups underwent sham exercise (supervised relaxation: one trial) or no intervention (five trials). None of the 89 participants allocated to exercise versus two of 84 participants in the control group died (RR 0.19, 95% CI 0.01 to 3.73; moderate-quality evidence). The cause of death was acute-on-chronic liver disease for both participants. Nine participants in the exercise group and 13 in the control group experienced serious adverse events (RR 0.61, 95% CI 0.19 to 1.94; low-quality evidence).Physical exercise showed no beneficial or detrimental effect on health-related quality of life assessed by the Chronic Liver Disease Questionnaire (MD 0.11, 95% CI -0.44 to 0.67; low-quality evidence). Likewise, physical exercise had no clear effect on physical fitness measured by peak exercise oxygen uptake (MD 0.3 mL/kg/minute, 95 % CI -2.74 to 3.35; low-quality evidence) and Six-Minute Walk Test (MD 56.06 min, 95% CI -9.14 to 121.26; very low-quality evidence). Physical exercise showed no clear effect on mid-thigh circumference (MD 1.76 cm, 95% CI -0.26 to 3.77; low-quality evidence), but showed an increase in mid-arm circumference (MD 2.61 cm, 95% CI 0.36 to 4.85; low-quality evidence). AUTHORS'
CONCLUSIONS: We found no clear beneficial or harmful effect of physical exercise on mortality, morbidity, or health-related quality of life. Further evidence is needed to evaluate the beneficial and harmful effects of physical exercise on clinical outcomes.

Entities:  

Mesh:

Year:  2018        PMID: 30575956      PMCID: PMC6517144          DOI: 10.1002/14651858.CD012678.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  85 in total

1.  Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches.

Authors:  Pamela Royle; Ruairidh Milne
Journal:  Int J Technol Assess Health Care       Date:  2003       Impact factor: 2.188

2.  Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis.

Authors:  Laura Zenith; Neha Meena; Ailar Ramadi; Milad Yavari; Andrea Harvey; Michelle Carbonneau; Mang Ma; Juan G Abraldes; Ian Paterson; Mark J Haykowsky; Puneeta Tandon
Journal:  Clin Gastroenterol Hepatol       Date:  2014-04-24       Impact factor: 11.382

Review 3.  Effects of physical activity upon the liver.

Authors:  Roy J Shephard; Nathan Johnson
Journal:  Eur J Appl Physiol       Date:  2014-11-04       Impact factor: 3.078

4.  Skeletal muscle strength and endurance in patients with mild COPD and the effects of weight training.

Authors:  C J Clark; L M Cochrane; E Mackay; B Paton
Journal:  Eur Respir J       Date:  2000-01       Impact factor: 16.671

Review 5.  An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease.

Authors:  Anne E Holland; Martijn A Spruit; Thierry Troosters; Milo A Puhan; Véronique Pepin; Didier Saey; Meredith C McCormack; Brian W Carlin; Frank C Sciurba; Fabio Pitta; Jack Wanger; Neil MacIntyre; David A Kaminsky; Bruce H Culver; Susan M Revill; Nidia A Hernandes; Vasileios Andrianopoulos; Carlos Augusto Camillo; Katy E Mitchell; Annemarie L Lee; Catherine J Hill; Sally J Singh
Journal:  Eur Respir J       Date:  2014-10-30       Impact factor: 16.671

Review 6.  Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses.

Authors:  Pranav Periyalwar; Srinivasan Dasarathy
Journal:  Clin Liver Dis       Date:  2012-01-23       Impact factor: 6.126

7.  Physical inactivity and insufficient dietary intake are associated with the frequency of sarcopenia in patients with compensated viral liver cirrhosis.

Authors:  Fumikazu Hayashi; Yoshinari Matsumoto; Chika Momoki; Miho Yuikawa; Genya Okada; Erika Hamakawa; Etsushi Kawamura; Atsushi Hagihara; Madoka Toyama; Hideki Fujii; Sawako Kobayashi; Shuji Iwai; Hiroyasu Morikawa; Masaru Enomoto; Akihiro Tamori; Norifumi Kawada; Daiki Habu
Journal:  Hepatol Res       Date:  2013-03-12       Impact factor: 4.288

Review 8.  Clinical relevance of sarcopenia in patients with cirrhosis.

Authors:  Aldo J Montano-Loza
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

9.  Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis.

Authors:  Eva Román; Maria Teresa Torrades; Maria Josep Nadal; Guillem Cárdenas; Juan Camilo Nieto; Sílvia Vidal; Helena Bascuñana; Cándido Juárez; Carlos Guarner; Juan Córdoba; Germán Soriano
Journal:  Dig Dis Sci       Date:  2014-03-06       Impact factor: 3.199

10.  Insulin resistance in euglycemic cirrhosis.

Authors:  Amitava Goswami; Narendra Bhargava; Sunil Dadhich; Ganaraj Kulamarva
Journal:  Ann Gastroenterol       Date:  2014
View more
  14 in total

1.  Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Andrea Gonzalez; Mayalen Valero-Breton; Camila Huerta-Salgado; Oscar Achiardi; Felipe Simon; Claudio Cabello-Verrugio
Journal:  Eur J Transl Myol       Date:  2021-03-26

Review 2.  Hepatogenous Diabetes: A Primer.

Authors:  Preetam Nath; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2021-05-01

3.  Physical exercise for people with cirrhosis.

Authors:  Luise Aamann; Gitte Dam; Anders R Rinnov; Hendrik Vilstrup; Lise Lotte Gluud
Journal:  Cochrane Database Syst Rev       Date:  2018-12-21

4.  Effects of moxibustion on symptoms of mild cognitive impairment: protocol of a systematic review and meta-analysis.

Authors:  Bin Li; Cun-Zhi Liu; Tao Zhang; Lin-Peng Wang; Gui-Ling Wang; Jing-Qing Sun; Xue-Wen Mao; Hui-Li Jiang
Journal:  BMJ Open       Date:  2020-04-28       Impact factor: 2.692

5.  Acupuncture for patients with premature ovarian insufficiency: A systematic review protocol.

Authors:  Li Huang; Yu Chen; Mei Luo; Yancai Tang; Shaobin Wei
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

Review 6.  Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver.

Authors:  Pankaj Puri; Radha K Dhiman; Sunil Taneja; Puneeta Tandon; Manuela Merli; Anil C Anand; Anil Arora; Subrat K Acharya; Jaya Benjamin; Yogesh K Chawla; Sunil Dadhich; Ajay Duseja; C E Eapan; Amit Goel; Naveen Kalra; Dharmesh Kapoor; Ashish Kumar; Kaushal Madan; Aabha Nagral; Gaurav Pandey; Padaki N Rao; Sanjiv Saigal; Neeraj Saraf; Vivek A Saraswat; Anoop Saraya; Shiv K Sarin; Praveen Sharma; Akash Shukla; Sandeep S Sidhu; Namrata Singh; Shivaram P Singh; Anshu Srivastava; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2020-10-01

7.  Adjuvant therapy of Chinese herbal medicine for the treatment of adenomyosis: A protocol for systematic review.

Authors:  Li Huang; Xiaoli Ji; Xia Wang; Yang Wu; Mei Luo; Xiaotong Hao; Shaobin Wei
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

8.  Gelomyrtol for acute or chronic sinusitis: A protocol for systematic review and meta-analysis.

Authors:  Yongcan Wu; Xiaomin Wang; Demei Huang; Caixia Pei; Shuiqin Li; Zhenxing Wang
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

9.  A systematic review and meta-analysis of the efficacy and safety of arbidol in the treatment of coronavirus disease 2019.

Authors:  Xuemei Wang; Ping Xie; Guojuan Sun; Min Zhao; Zhumei Deng; Yunxia Zhou; Shuting Bao
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

10.  The efficacy and safety of Lianhua Qingwen (LHQW) for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis.

Authors:  Qiongshuai Zhang; Fang Cao; Guangcheng Ji; Xiaohong Xu; Yihan Sun; Jiannan Li; Xun Qi; Shaoqian Sun; Yufeng Wang; Bailin Song
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.